Cleveland Biolabs (CBLI) Reports Q3 Loss of $0.31
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.: 1.14M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.: 1.14M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q3 EPS of ($0.31), versus $1.43 reported last year. Revenue for the quarter came in at $501 thousand, versus $415 million reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Is Treasury selloff a major issue for stock market bulls?
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
